menu search

INDV / Indivior to pay $30 million to settle health plans' Suboxone claims

Indivior to pay $30 million to settle health plans' Suboxone claims
Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. Read More
Posted: Aug 21 2023, 14:46
Author Name: Reuters
Views: 102857

INDV News  

Indivior's $385m settement heads off prolonged court action; shares up 4%

By Proactive Investors
October 23, 2023

Indivior's $385m settement heads off prolonged court action; shares up 4%

Drugmaker Indivior PLC (LSE:INDV) has agreed to a $385 million settlement over allegations of illegally hindering generic competition for its opioid a more_horizontal

Indivior to pay $385 mln to end Suboxone monopoly lawsuits

By Reuters
October 23, 2023

Indivior to pay $385 mln to end Suboxone monopoly lawsuits

Drugmaker Indivior said on Monday it will pay $385 million to settle a lawsuit brought by direct purchasers on claims it illegally suppressed generic more_horizontal

Indivior PLC (INDV) is on the Move, Here's Why the Trend Could be Sustainable

By Zacks Investment Research
August 29, 2023

Indivior PLC (INDV) is on the Move, Here's Why the Trend Could be Sustainable

Indivior PLC (INDV) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. more_horizontal

Indivior to pay $30 million to settle health plans' Suboxone claims

By Reuters
August 21, 2023

Indivior to pay $30 million to settle health plans' Suboxone claims

Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally supp more_horizontal


Search within

Pages Search Results: